866-997-4948(US-Canada Toll Free)

Exocrine Pancreatic Insufficiency (EPI) Therapeutics and Diagnostics Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2017 - 2025

Published By :

Transparency Market Research

Published Date : Feb 2018

Category :

MRI

No. of Pages : 154 Pages

Exocrine Pancreatic Insufficiency (EPI) Therapeutics and Diagnostics Market: Overview

The report on the exocrine pancreatic insufficiency (EPI) therapeutics & diagnostics market analyzes the current and future scenario of the global market. Rise in the prevalence of cystic fibrosis and chronic pancreatitis, and increase in prevalence of diabetes across the world are the major drivers of the global exocrine pancreatic insufficiency (EPI) therapeutics & diagnostics market.

The exocrine pancreatic insufficiency (EPI) therapeutics & diagnostics market report comprises an elaborate executive summary, which includes a market snapshot that provides information about various segments of the market. It also provides information and data analysis of the global exocrine pancreatic insufficiency (EPI) therapeutics & diagnostics market with respect to the segments based on therapeutics & diagnostics types, and geography. A detailed qualitative analysis of drivers and restraints of the market and its opportunities have been provided in the market overview section. This section of the report also provides market attractiveness analysis, by geography and market share analysis by key players, thus presenting a thorough analysis of the overall competitive scenario in the global exocrine pancreatic insufficiency (EPI) therapeutics & diagnostics market.

Exocrine Pancreatic Insufficiency (EPI) Therapeutics and Diagnostics Market: Segmentation

Based on type, the exocrine pancreatic insufficiency (EPI) therapeutics & diagnostics market is segmented as therapeutics & diagnostics. The diagnostics segment is again sub-segmented into blood tests, endoscopic ultra-sonography, magnetic resonance imaging [MRI], and CT scanning. The market size and forecast, in terms of value, for each of these segments have been provided for the period from 2015 to 2025, along with their respective CAGRs for the forecast period from 2017 to 2025, considering 2016 as the base year.

Geographically, the global exocrine pancreatic insufficiency (EPI) therapeutics & diagnostics market has been categorized into five major regions and the key countries in the respective regions: North America (the U.S., Canada), Europe (the U.K., Germany, France, Spain, Italy, and Rest of Europe), Asia Pacific (Japan, India, China, Australia and Rest of Asia Pacific), Latin America (Brazil, Mexico, and Rest of Latin America) and Middle East & Africa (South Africa, GCC countries, and Rest of Middle East & Africa). The market size and forecast for each of these regions and the mentioned countries have been provided for the period from 2015 to 2025, along with their respective CAGRs for the forecast period from 2017 to 2025, considering 2016 as the base year. The country wise market size and analysis for each segment in terms of value has been provided in the report. The research study also covers the competitive scenario in these regions.

Exocrine Pancreatic Insufficiency (EPI) Therapeutics and Diagnostics Market: Competitive Dynamics

The report also profiles major players in the global exocrine pancreatic insufficiency (EPI) therapeutics & diagnostics market based on various attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments. Major players profiled in this report include – Abbvie, Inc., Allergan plc, Nordmark Arzneimittel GmbH & Co. KG, Digestive Care, Inc., Janssen Pharmaceuticals, Inc., Cilian AG, Anthera Pharmaceuticals, Inc., AzurRx Biopharma, Inc. and others.

The global exocrine pancreatic insufficiency (EPI) therapeutics & diagnostics market is segmented as given below:

Global Exocrine Pancreatic Insufficiency (EPI) Therapeutics & Diagnostics Market, by Type

  • Therapeutics
  • Diagnostics
    • Blood Tests
    • Endoscopic Ultra-sonography (EUS)
    • Magnetic Resonance Imaging (MRI)
    • CT Scanning

Global Exocrine Pancreatic Insufficiency (EPI) Therapeutics & Diagnostics Market, by Geography

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • U.K.
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • India
    • China
    • Australia & New Zealand
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC countries
    • South Africa
    • Rest of Middle East & Africa

 

Table of Content

Chapter 1. Preface
1.1. Report Scope and Market Segmentation
1.2. Research Highlights

Chapter 2. Assumptions and Research Methodology
2.1. Assumptions
2.2. Research Methodology

Chapter 3. Executive Summary : Global Exocrine Pancreatic Insufficiency (EPI) Therapeutics & Diagnostics Market
3.1. Global Exocrine Pancreatic Insufficiency (EPI) Therapeutics & Diagnostics Market Size (US$ Mn) and Distribution by Geography, 2017 and 2025
3.2. Global Exocrine Pancreatic Insufficiency (EPI) Therapeutics & Diagnostics Market Snapshot, 2016
3.3. Global Exocrine Pancreatic Insufficiency (EPI) Therapeutics & Diagnostics Market : Opportunity Map

Chapter 4. Market Overview
4.1. Overview
4.2. Global Exocrine Pancreatic Insufficiency (EPI) Therapeutics & Diagnostics Market Size (US$ Mn) Forecast, 2015–2025
4.3. Global Exocrine Pancreatic Insufficiency (EPI) Therapeutics & Diagnostics Market Outlook
4.4. U.S. Exocrine Pancreatic Insufficiency Therapeutics Market, Brand Analysis
4.5. Global Exocrine Pancreatic Insufficiency (EPI) Therapeutics Market : Pipeline Analysis
4.6. Exocrine Pancreatic Insufficiency (EPI) Therapeutics Market : U.S. Market Trend & Analysis

Chapter 5. Market Dynamics
5.1. Drivers
5.1.1. Rise in prevalence of cystic fibrosis and chronic pancreatitis
5.1.2. Increase in prevalence of diabetes across the world
5.2. Restrains
5.2.1. Stringent FDA regulations
5.2.2. Drawbacks of current PERT products
5.3. Opportunity Analysis
5.4. Opportunities
5.4.1. Pipeline products intended to be substitutes for PERT products
5.4.2. Emerging economies to offer sustained growth opportunities

Chapter 6. Exocrine Pancreatic Insufficiency (EPI) Therapeutics & Diagnostics Market Analysis, by Type
6.1. Introduction
6.2. Global Exocrine Pancreatic Insufficiency (EPI) Therapeutics & Diagnostics Market Value Share Analysis, by Type
6.3. Exocrine Pancreatic Insufficiency (EPI) Therapeutics & Diagnostics Market Analysis, by Type
6.3.1. Therapeutics
6.3.2. Diagnostics
6.3.2.1. Blood Tests
6.3.2.2. Endoscopic Ultra-sonography (EUS)
6.3.2.3. Magnetic Resonance Imaging (MRI)
6.3.2.4. CT Scanning
6.4. Exocrine Pancreatic Insufficiency (EPI) Therapeutics & Diagnostics Market Attractiveness Analysis, by Type
6.5. Exocrine Pancreatic Insufficiency (EPI) Therapeutics & Diagnostics Market Attractiveness Analysis, by Diagnostics

Chapter 7. Exocrine Pancreatic Insufficiency (EPI) Therapeutics & Diagnostics Market Analysis, by Region
7.1. Global Exocrine Pancreatic Insufficiency (EPI) Therapeutics & Diagnostics Market Snapshot, by Country
7.2. Global Exocrine Pancreatic Insufficiency (EPI) Therapeutics & Diagnostics Market Value Share Analysis, by Region
7.3. Exocrine Pancreatic Insufficiency (EPI) Therapeutics & Diagnostics Market Forecast, by Region
7.4. Exocrine Pancreatic Insufficiency (EPI) Therapeutics & Diagnostics Market Attractiveness Analysis, by Region
7.5. Key Market Trends By Region

Chapter 8. North America Exocrine Pancreatic Insufficiency (EPI) Therapeutics & Diagnostics Market Analysis
8.1. Key Findings
8.2. North America Exocrine Pancreatic Insufficiency (EPI) Therapeutics & Diagnostics Market Overview
8.3. North America Market Value Share Analysis, by Type
8.4. North America Market Forecast, by Type
8.5. Market Analysis, by Country
8.6. Market Value Share Analysis, by Country
8.7. Market Size (US$ Mn) Forecast, by Country, 2017–2025
8.7.1. U.S.
8.7.2. Canada
8.8. Market Attractiveness Analysis
8.9. By Type
8.10. By Country

Chapter 9. Europe Exocrine Pancreatic Insufficiency (EPI) Therapeutics & Diagnostics Market Analysis
9.1. Key Findings
9.2. Europe Exocrine Pancreatic Insufficiency (EPI) Therapeutics & Diagnostics Market Overview
9.3. Europe Market Value Share Analysis, by Type
9.4. Europe Market Forecast, by Type
9.5. Market Analysis, by Country
9.6. Market Value Share Analysis, by Country
9.7. Market Size (US$ Mn) Forecast, by Country, 2017–2025
9.7.1. Germany
9.7.2. France
9.7.3. U.K.
9.7.4. Spain
9.7.5. Italy
9.7.6. Rest of Europe
9.8. Market Attractiveness Analysis
9.8.1. By Type
9.8.2. By Country

Chapter 10. Asia Pacific Exocrine Pancreatic Insufficiency (EPI) Therapeutics & Diagnostics Market Analysis
10.1. Key Findings
10.2. Asia Pacific Exocrine Pancreatic Insufficiency (EPI) Therapeutics & Diagnostics Market Overview
10.3. Asia Pacific Market Value Share Analysis, by Type
10.4. Asia Pacific Market Forecast, by Type
10.5. Market Analysis, by Country
10.6. Market Value Share Analysis, by Country
10.7. Market Size (US$ Mn) Forecast, by Country, 2017–2025
10.7.1. Japan
10.7.2. China
10.7.3. India
10.7.4. Australia & New Zealand
10.7.5. Rest of Asia Pacific
10.8. Market Attractiveness Analysis
10.8.1. By Type
10.8.2. By Country

Chapter 11. Latin America Exocrine Pancreatic Insufficiency (EPI) Therapeutics & Diagnostics Market Analysis
11.1. Key Findings
11.2. Latin America Exocrine Pancreatic Insufficiency (EPI) Therapeutics & Diagnostics Market Overview
11.3. Latin America Market Value Share Analysis, by Type
11.4. Latin America Market Forecast, by Type
11.5. Market Analysis, by Country
11.6. Market Value Share Analysis, by Country
11.7. Market Size (US$ Mn) Forecast, by Country, 2017–2025
11.7.1. Brazil
11.7.2. Mexico
11.7.3. Rest of Latin America
11.8. Market Attractiveness Analysis
11.8.1. By Type
11.8.2. By Country

Chapter 12. Middle East & Africa Exocrine Pancreatic Insufficiency (EPI) Therapeutics & Diagnostics Market Analysis
12.1. Key Findings
12.2. Middle East & Africa Exocrine Pancreatic Insufficiency (EPI) Therapeutics & Diagnostics Market Overview
12.3. Middle East & Africa Market Value Share Analysis, by Type
12.4. Middle East & Africa Market Forecast, by Type
12.5. Market Analysis, by Country
12.6. Market Value Share Analysis, by Country
12.7. Market Size (US$ Mn) Forecast, by Country, 2017–2025
12.7.1. GCC Countries
12.7.2. South Africa
12.7.3. Rest of Middle East & Africa
12.8. Market Attractiveness Analysis
12.8.1. By Type
12.8.2. By Country

Chapter 13. Competition Landscape
13.1. Global Exocrine Pancreatic Insufficiency (EPI) Therapeutics & Diagnostics Market Share Analysis, by Company, 2016
13.2. Competition Matrix
13.3. Company Profiles
13.3.1. AbbVie, Inc.
13.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
13.3.1.2. Financial Overview
13.3.1.3. Product Portfolio
13.3.1.4. SWOT Analysis
13.3.1.5. Strategic Overview
13.3.2. Allergan plc
13.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
13.3.2.2. Financial Overview
13.3.2.3. Product Portfolio
13.3.2.4. SWOT Analysis
13.3.2.5. Strategic Overview
13.3.3. Nordmark Arzneimittel GmbH & Co. KG
13.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
13.3.3.2. Product Portfolio
13.3.3.3. SWOT Analysis
13.3.3.4. Strategic Overview
13.3.4. Digestive Care, Inc.
13.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
13.3.4.2. Product Portfolio
13.3.4.3. SWOT Analysis
13.3.4.4. Strategic Overview
13.3.5. Janssen Pharmaceuticals, Inc.
13.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
13.3.5.2. Financial Overview
13.3.5.3. Product Portfolio
13.3.5.4. SWOT Analysis
13.3.5.5. Strategic Overview
13.3.6. Cilian AG
13.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
13.3.6.2. Product Portfolio
13.3.6.3. SWOT Analysis
13.3.6.4. Strategic Overview
13.3.7. Anthera Pharmaceuticals, Inc.
13.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
13.3.7.2. Financial Overview
13.3.7.3. Product Portfolio
13.3.7.4. SWOT Analysis
13.3.7.5. Strategic Overview
13.3.8. AzurRx Biopharma, Inc.
13.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
13.3.8.2. Product Portfolio
13.3.8.3. SWOT Analysis
13.3.8.4. Strategic Overview

List of Table

Table 01: U.S. EPI Therapeutics Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, By Brands, 2016–2025
Table 02: EPI Therapeutics Brands in the U.S.
Table 03: Global EPI Therapeutics Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, By Pipeline Products, 2019–2025
Table 04: Global EPI Therapeutics & Diagnostics Market Size (US$ Mn) Forecast, by Type, 2015–2025
Table 05: Global EPI Therapeutics & Diagnostics Market Size (US$ Mn) Forecast, by Diagnostics, 2015–2025
Table 06: Global EPI Therapeutics & Diagnostics Market Value (US$ Mn) Forecast, by Region, 2015–2025
Table 07: Global EPI Therapeutics Market Value (US$ Mn) Forecast, by Region, 2015–2025
Table 08: Global EPI Diagnostics Market Value (US$ Mn) Forecast, by Region, 2015–2025
Table 09: North America EPI Therapeutics & Diagnostics Market Value (US$ Mn) Forecast, by Country, 2015–2025
Table 10: North America EPI Therapeutics Market Value (US$ Mn) Forecast, by Country, 2015–2025
Table 11: North America EPI Diagnostics Market Value (US$ Mn) Forecast, by Country, 2015–2025
Table 12: North America EPI Therapeutics & Diagnostics Market Size (US$ Mn) Forecast, by Type, 2015–2025
Table 13: North America EPI Therapeutics & Diagnostics Market Size (US$ Mn) Forecast, by Diagnostics, 2015–2025
Table 14: Europe EPI Therapeutics & Diagnostics Market Value (US$ Mn) Forecast, by Country, 2015–2025
Table 15: Europe EPI Therapeutics Market Value (US$ Mn) Forecast, by Country, 2015–2025
Table 16: Europe EPI Diagnostics Market Value (US$ Mn) Forecast, by Country, 2015–2025
Table 17: Europe EPI Therapeutics & Diagnostics Market Size (US$ Mn) Forecast, by Type, 2015–2025
Table 18: Europe EPI Therapeutics & Diagnostics Market Size (US$ Mn) Forecast, by Diagnostics, 2015–2025
Table 19: Asia Pacific EPI Therapeutics & Diagnostics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2015–2025
Table 20: Asia Pacific EPI Therapeutics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2015–2025
Table 21: Asia Pacific EPI Diagnostics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2015–2025
Table 22: Asia Pacific EPI Therapeutics & Diagnostics Market Size (US$ Mn) Forecast, by Type, 2015–2025
Table 23: Asia Pacific EPI Therapeutics & Diagnostics Market Size (US$ Mn) Forecast, by Diagnostics, 2015–2025
Table 24: Latin America EPI Therapeutics & Diagnostics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2015–2025
Table 25: Latin America EPI Therapeutics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2015–2025
Table 26: Latin America EPI Diagnostics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2015–2025
Table 27: Latin America EPI Therapeutics & Diagnostics Market Size (US$ Mn) Forecast, by Type, 2015–2025
Table 28: Latin America EPI Therapeutics & Diagnostics Market Size (US$ Mn) Forecast, by Diagnostics, 2015–2025
Table 29: Middle East & Africa EPI Therapeutics & Diagnostics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2015–2025
Table 30: Middle East & Africa EPI Therapeutics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2015–2025
Table 31: Middle East & Africa EPI Diagnostics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2015–2025
Table 32: Middle East & Africa EPI Therapeutics & Diagnostics Market Size (US$ Mn) Forecast, by Type, 2015–2025
Table 33: Middle East & Africa EPI Therapeutics & Diagnostics Market Size (US$ Mn) Forecast, by Diagnostics, 2015–2025

List of Chart

Figure 01: Acronyms
Figure 02: Global EPI Therapeutics & Diagnostics Market Size (US$ Mn) and Distribution, by Region, 2017 and 2025
Figure 03: Global EPI Therapeutics & Diagnostics Market Snapshot, 2016
Figure 04: Market Opportunity Map, 2016
Figure 05: Global EPI Therapeutics & Diagnostics Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2015–2025
Figure 06: EPI Therapeutics & Diagnostics Market Value Share, by Type (2016)
Figure 07: EPI Therapeutics & Diagnostics Market Value Share, by Diagnostics (2016)
Figure 08: EPI Therapeutics & Diagnostics Market Value Share, by Region (2016)
Figure 09: Total U.S. sales and number of prescriptions of pancreatic enzyme products (PEPs) from 2008-2012 in the United States
Figure 10: Cost per prescription (U.S. Dollars) and number of pancreatic enzyme products (PEPs) marketed in the United States from 2008-12 
Figure 11: Drivers and Restraints Snapshot Figure 151: Global Exocrine Pancreatic Insufficiency (EPI) Therapeutics & Diagnostics Market Share, by Company, 2016
Figure 12: Global EPI Therapeutics & Diagnostics Market Value Share, by Type, 2017 and 2025
Figure 13: Global EPI Therapeutics & Diagnostics Market Attractiveness Analysis, by Type, 2017–2025
Figure 14: Global EPI Therapeutics & Diagnostics Market Value Share, by Diagnostics, 2017 and 2025
Figure 15: Global EPI Therapeutics & Diagnostics Market Attractiveness, by Diagnostics, 2017–2025
Figure 16: Global Exocrine Pancreatic Insufficiency Market Revenue (US$ Mn) Forecast, by Therapeutics, 2015–2025
Figure 17: Global Exocrine Pancreatic Insufficiency Market Revenue (US$ Mn) Forecast, by Diagnostics, 2015–2025
Figure 18: Global Exocrine Pancreatic Insufficiency Diagnostics Market Revenue (US$ Mn) Forecast, by Blood Tests, 2015–2025
Figure 19: Global Exocrine Pancreatic Insufficiency Diagnostics Market Revenue (US$ Mn) Forecast, by Endoscopic Ultra- sonography (EUS), 2015–2025
Figure 20: Global Exocrine Pancreatic Insufficiency Diagnostics Market Revenue (US$ Mn) Forecast, by Magnetic Resonance Imaging (MRI), 2015–2025
Figure 21: Global Exocrine Pancreatic Insufficiency Diagnostics Market Revenue (US$ Mn) Forecast, by CT Scanning, 2015–2025
Figure 22: Global EPI Therapeutics & Diagnostics Market Value Share, by Region, 2017 and 2025
Figure 23: Global EPI Therapeutics & Diagnostics Market Attractiveness, by Region, 2017–2025
Figure 24: North America EPI Therapeutics & Diagnostics Market Value (US$ Mn) and Y-o-Y Growth (%), 2015–2025
Figure 25: North America EPI Therapeutics Market Value (US$ Mn) and Y-o-Y Growth (%), 2015–2025
Figure 26: North America EPI Diagnostics Market Value (US$ Mn) and Y-o-Y Growth (%), 2015–2025
Figure 27: North America EPI Therapeutics & Diagnostics Market Value Share, by Country, 2017 and 2025
Figure 28: North America EPI Therapeutics & Diagnostics Market Attractiveness, by Country, 2017–2025
Figure 29: North America EPI Therapeutics & Diagnostics Market Value Share, by Type, 2017 and 2025
Figure 30: North America EPI Therapeutics & Diagnostics Market Attractiveness, by Type, 2017–2025
Figure 31: Europe EPI Therapeutics & Diagnostics Market Value (US$ Mn), 2015–2025
Figure 32: Europe EPI Therapeutics Market Value (US$ Mn), 2015–2025
Figure 33: Europe EPI Diagnostics Market Value (US$ Mn), 2015–2025
Figure 34: Europe EPI Therapeutics & Diagnostics Market Value Share, by Country, 2017 and 2025
Figure 35: Europe EPI Therapeutics & Diagnostics Market Attractiveness, by Country, 2017–2025
Figure 36: Europe EPI Therapeutics & Diagnostics Market Value Share, by Type, 2017 and 2025
Figure 37: Europe EPI Therapeutics & Diagnostics Market Attractiveness, by Type, 2017–2025
Figure 38: Asia Pacific EPI Therapeutics & Diagnostics Market Value (US$ Mn) and Y-o-Y Growth (%), 2015–2025
Figure 39: Asia Pacific EPI Therapeutics & Diagnostics Market Value (US$ Mn) and Y-o-Y Growth (%), by Therapeutics, 2015–2025
Figure 40: Asia Pacific EPI Therapeutics & Diagnostics Market Value (US$ Mn) and Y-o-Y Growth (%), by Diagnostics, 2015–2025
Figure 41: Asia Pacific EPI Therapeutics & Diagnostics Market Value Share, by Country/Sub-region, 2017 and 2025
Figure 42: Asia Pacific EPI Therapeutics & Diagnostics Market Attractiveness, by Country/Sub-region, 2017–2025
Figure 43: Asia Pacific EPI Therapeutics & Diagnostics Market Value Share, by Type, 2017 and 2025
Figure 44: Asia Pacific EPI Therapeutics & Diagnostics Market Attractiveness, by Type, 2017–2025
Figure 45: Latin America EPI Therapeutics & Diagnostics Market Value (US$ Mn), 2015–2025
Figure 46: Latin America EPI Therapeutics Market Value (US$ Mn), 2015–2025
Figure 47: Latin America EPI Diagnostics Market Value (US$ Mn), 2015–2025
Figure 48: Latin America EPI Therapeutics & Diagnostics Market Value Share, by Country/Sub-region, 2017 and 2025
Figure 49: Latin America EPI Therapeutics & Diagnostics Market Attractiveness, by Country/Sub-region, 2017–2025
Figure 50: Latin America EPI Therapeutics & Diagnostics Market Value Share, by Type, 2017 and 2025
Figure 51: Latin America EPI Therapeutics & Diagnostics Market Attractiveness, by Type, 2017–2025
Figure 52: Middle East & Africa EPI Therapeutics & Diagnostics Market Value (US$ Mn) and Y-o-Y Growth (%), 2015–2025
Figure 53: Middle East & Africa EPI Therapeutics & Diagnostics Market Value (US$ Mn), by Therapeutics, 2015–2025
Figure 54: Middle East & Africa EPI Therapeutics & Diagnostics Market Value (US$ Mn), by Diagnostics, 2015–2025
Figure 55: Middle East & Africa EPI Therapeutics & Diagnostics Market Value Share, by Country/Sub-region, 2017 and 2025
Figure 56: Middle East & Africa EPI Therapeutics & Diagnostics Market Attractiveness, by Country/Sub-region, 2017–2025
Figure 57: Middle East & Africa EPI Therapeutics & Diagnostics Market Value Share, by Type, 2017 and 2025
Figure 58: Middle East & Africa EPI Therapeutics & Diagnostics Market Attractiveness, by Type, 2017–2025
Figure 59: Global EPI Therapeutics Market Share, by Company, 2016 
Figure 60: AbbVie, Inc. Revenue (US$ Bn) and Y-o-Y Growth (%), 2013–2016
Figure 61: AbbVie, Inc. Breakdown of Net Sales, by Region, 2016 
Figure 62: Janssen Pharmaceuticals, Inc. Revenue (US$ Mn) and Y-o-Y Growth (%), 2013–2016
Figure 63: Janssen Pharmaceuticals, Inc. Breakdown of Net Sales, by Region, 2016 
Figure 64: Allergan plc Revenue (US$ Bn) and Y-o-Y Growth (%), 2013–2016
Figure 65: Allergan plc Breakdown of Net Sales, by Segment, 2016 
Figure 66: Anthera Pharmaceuticals, Inc. Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2016
Figure 67: Anthera Pharmaceuticals, Inc. R&D Expenditure, 2013–2016

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title
  • Company
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *